1. Abstract
Since the announcement of the pandemic of Covid-19 by WHO on March 11, 2020, the countries have started to monitor surveillance of SARS-CoV-2 through medical tests. However, people with no and very light symptoms are usually not medically tested or never hospitalized and they are missed. In the study of Wu et al. [1], it was realized that the urine and faeces of all infected people contain SARS-CoV-2. After that, sewage, and sludge-based SARS-CoV-2 surveillance studies have gained significant importance around the world (Fig.1). SARS-CoV-2 was detected in wastewaters in The Netherlands [2,3,4], USA [1,5,6,7, 8, 9, 10], Australia [11], France [12, 13, 14], China [15], Spain [16,17,18,19,20], Italy [21, 22,23], Israel [24], Turkey[25], Germany[26], Japan [27,28], India [29,30], Pakistan [31], Brazil [32,33], Chile [34], Denmark, France, Belgium[35], Equator [36] and Sweden [37] using different virus concentration techniques. Published data show that high concentrations of the SARS-CoV-2 RNA reaches to wastewater treatment plants (WWTPs). On 7th of May 2020, Turkey took its place among a few country which have been started wastewater based surveillance studies at the early stages of pandemic by reporting SARS-CoV-2 RT-qPCR levels of major WWTPs of Istanbul [25]. Turkey [38] first detected SARS-CoV-2 in both primary and waste activated sludges of Istanbul WWTPs. Later, USA [39] and Spain [40] were also studied on sludge samples. There are also studies evaluating the SARS-CoV-2 in WWTPs effluents [10,13,14, 28, 29,30, 34, 36].
This study aimed to scan distribution of Covid-19 through Turkey by SARS-CoV-2 measurements in influent, effluent and sludge samples of WWTPs. The influent, effluent and sludge samples were collected from main WWTPs located in 81 cities of Turkey through May 2020-July 2020. Among those 81 cities, Istanbul metropole with 15.5 million inhabitants was chosen as the pilot city since 65% of all cases in Turkey were present here. Hence, all treatment plants in Istanbul were scanned through the study. The viral activity tests were also conducted for the influent, effluent and sludge samples resulting high qPCR.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was financed by Republic of Turkey, Ministry of Agriculture and Forestry
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No need for ethics committee
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
ll data referred to in the manusrpt are available
